Neil E. Bhola

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer”.

Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer

JCI Insight(2021)10.1172/jci.insight.151982

N/A

0.791DataRank · unranked

19 citations

Rex H. Lee, Hua Li, Neil E. Bhola, Rachel A. O’Keefe, Mohammad Naser +16 more

Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer

Cancer Cell(2025)10.1016/j.ccell.2025.07.015

N/A

0.359DataRank · unranked

8 citations

Katherine A. Skorupski, Ning Cheng, Zhibin Cui, Hua Li, Liam C. Woerner +15 more

Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance

PLoS ONE(2020)10.1371/journal.pone.0227261

N/A

0DataRank · unranked

8 citations

Neil E. Bhola, David S. Lee, Daniel E. Johnson, Jennifer R. Grandis, Rachel A. O’Keefe

Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast Cancer

UNC Libraries(2020)10.17615/jyfd-8k67

N/A

0DataRank · unranked

0 citations

Meghan M. Morrison, Rebecca S. Cook, Dana M. Brantley‐Sieders, D.C. Liebler, Joyce O’Shaughnessy +23 more